News for VolitionRx Limited (VNRX)

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiat...

Operator: Good afternoon ladies and gentlemen and thank you for standing by. Welcome to VolitionRx Limited Fourth Quarter and Full Fiscal Year 2024 Earnings Conference Call.

VolitionRx Limited (NYSE:VNRX) Q4 2024 Earnings Conference Call March 31, 2025 4:30 PM ETCompany ParticipantsLouise Batchelor - Chief Marketing &...

PR NewswireHENDERSON, Nev., March 28, 2025 Studies demonstrate how Volition's Nu.Q®H3K27Me3 biomarker, when combined with ctDNA, may improve the prognosti

PR NewswireHENDERSON, Nev., March 21, 2025 Volition study shows rapid, low-cost, automated Nu.Q® Cancer test accurately detects human cancers at high spec

PR NewswireHENDERSON, Nev., March 20, 2025 "Lung Cancer: Hope of a Brighter Tomorrow" illustrates how Nu.Q® Cancer Test aims to transform the diagnosis,

PR NewswireHENDERSON, Nev., March 17, 2025 Volition to host multiple presentations at the International Symposium on Intensive Care & Emergency Medicine in

PR NewswireHENDERSON, Nev., March 13, 2025 HENDERSON, Nev., March 13, 2025 /PRNewswire/ -- VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition"), a multi-n

PR NewswireHENDERSON, Nev., March 11, 2025 Published study shows Nu.Q® Lung Cancer Test differentiated malignant and benign nodules found by Low Dose CT s

PR NewswireHENDERSON, Nev., March 4, 2025 Nu.Q® Discover tools provide drug developers and scientists with a range of rapid epigenetic profiling assays ac

PR NewswireHENDERSON, Nev., Feb. 28, 2025 Volition will showcase presentations from Dr. Sue Ettinger, aka Dr. Sue Cancer Vet, Dr. Brett Cordes, DVM, and Dr

PR NewswireHENDERSON, Nev., Dec. 12, 2024 Volition to participate in the upcoming 14th Annual LifeSci Partners Corporate Access Event on January 15th, 2025

Volitionrx director Innes buys $99,999 in common stock

PR NewswireHENDERSON, Nev, Dec. 6, 2024 Up to $1.9 million up front with up to an additional $2.7 million of potential aggregate gross proceeds upon the ex

Operator: Good day, ladies and gentlemen. Thank you for standing by. Welcome to VolitionRx Limited's Third Quarter 2024 Earnings Conference Call.

VolitionRx Limited (NYSE:VNRX) Q3 2024 Earnings Conference Call November 15, 2024 8:30 AM ETCompany ParticipantsLouise Batchelor - Chief Marketing &...

Volition to share new 'NETs in sepsis management' data insights at upcoming webinar

Aspira Womens Health (AWH) experienced a significant stock price drop of 7.80%, reaching $0.775 per share. The trading volume stood at 14,064 shares with a turn

Neogen Corporation (NEOG) experienced a sudden stock price drop of 5.03%, settling at $14.92 per share. This movement came with a trading volume of 355,098 shar